Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Muscle Neoplasms"" wg kryterium: Temat


Tytuł:
Cotyledonoid dissecting leiomyoma of the uterus: a case report and review of the literature.
Autorzy:
Chahkandi M; Department of Pathology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Ataei M; Department of Obstetrics and Gynecology, Clinical Research Development Unit, Vali-e-Asr Hospital, Birjand University of Medical Sciences, Birjand, Iran.
Bina AR; Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Mozayani F; Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.; Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Fanoodi A; Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran. .
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2023 Dec 16; Vol. 17 (1), pp. 516. Date of Electronic Publication: 2023 Dec 16.
Typ publikacji:
Review; Case Reports; Journal Article
MeSH Terms:
Uterine Neoplasms*/diagnostic imaging
Uterine Neoplasms*/surgery
Leiomyoma*/diagnostic imaging
Leiomyoma*/surgery
Muscle Neoplasms*/pathology
Female ; Humans ; Middle Aged ; Iran ; Uterus/diagnostic imaging ; Uterus/surgery ; Uterus/pathology ; Hysterectomy
Czasopismo naukowe
Tytuł:
2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle.
Autorzy:
Wei L; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Wang R; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Wazir J; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Lin K; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Song S; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Li L; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Pu W; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Zhao C; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Wang Y; Medical School, State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Nanjing University, Nanjing 210093, China.
Su Z; Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Wang H; Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Sep 25; Vol. 11 (19). Date of Electronic Publication: 2022 Sep 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/metabolism
Muscle Neoplasms*/metabolism
Adenosine Triphosphate/metabolism ; Animals ; Cachexia/etiology ; Cachexia/metabolism ; Deoxyglucose/metabolism ; Deoxyglucose/pharmacology ; Glucose/metabolism ; Humans ; Ketones/pharmacology ; Lactates/metabolism ; Lipids/pharmacology ; Mice ; Muscle, Skeletal/metabolism ; Muscular Atrophy/metabolism ; Proteasome Endopeptidase Complex/metabolism ; Ubiquitins/metabolism
Czasopismo naukowe
Tytuł:
Comparison of reduced field-of-view DWI and full field-of view DWI for the differentiation between non-muscle invasive bladder cancer and muscle invasive bladder cancer using VI-RADS.
Autorzy:
Juri H; Department of Diagnostic Radiology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Higashiyama A; Department of Diagnostic Radiology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Yamamoto K; Department of Diagnostic Radiology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Narumi Y; Department of Health Care, Osaka Medical Association Center, Osaka, Japan.
Azuma H; Department of Urology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Yamamoto K; Department of Diagnostic Radiology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Osuga K; Department of Diagnostic Radiology, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 20; Vol. 17 (7), pp. e0271470. Date of Electronic Publication: 2022 Jul 20 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Diffusion Magnetic Resonance Imaging*/methods
Muscle Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Area Under Curve ; Diagnosis, Differential ; Humans ; Neoplasm Invasiveness/diagnostic imaging ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
CRTC1-SS18 Fusion Sarcoma With Aberrant Anaplastic Lymphoma Kinase Expression.
Autorzy:
Pan R; Jinling Hospital, 144990Medical School of Nanjing University, Nanjing, China.
Wang Z; School of Medicine & Holistic Integrative Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing, China.
Wang X; Jinling Hospital, 144990Medical School of Nanjing University, Nanjing, China.
Fang R; Jinling Hospital, 144990Medical School of Nanjing University, Nanjing, China.
Xia Q; Jinling Hospital, 144990Medical School of Nanjing University, Nanjing, China.
Rao Q; Jinling Hospital, 144990Medical School of Nanjing University, Nanjing, China.
Pokaż więcej
Źródło:
International journal of surgical pathology [Int J Surg Pathol] 2022 Feb; Vol. 30 (1), pp. 99-105. Date of Electronic Publication: 2021 May 31.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Anaplastic Lymphoma Kinase/*metabolism
Biomarkers, Tumor/*metabolism
Muscle Neoplasms/*diagnosis
Oncogene Proteins, Fusion/*genetics
Proto-Oncogene Proteins/*genetics
Repressor Proteins/*genetics
Sarcoma/*diagnosis
Transcription Factors/*genetics
Adult ; Female ; Humans ; Muscle Neoplasms/genetics ; Muscle Neoplasms/metabolism ; Muscle Neoplasms/pathology ; Muscle, Skeletal/metabolism ; Muscle, Skeletal/pathology ; Oncogene Fusion ; Sarcoma/genetics ; Sarcoma/metabolism ; Sarcoma/pathology
Czasopismo naukowe
Tytuł:
Epstein-Barr virus associated smooth muscle neoplasm postlung transplantation.
Autorzy:
Ennis S; Lung Transplant Unit, St Vincent's Hospital, Sydney, New South Wales, Australia.
Plit M; Lung Transplant Unit, St Vincent's Hospital, Sydney, New South Wales, Australia.
Malouf M; Lung Transplant Unit, St Vincent's Hospital, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Feb; Vol. 24 (1), pp. e13756. Date of Electronic Publication: 2021 Dec 14.
Typ publikacji:
Letter
MeSH Terms:
Epstein-Barr Virus Infections*/diagnosis
Kidney Transplantation*
Muscle Neoplasms*
Smooth Muscle Tumor*/diagnosis
Herpesvirus 4, Human ; Humans
Opinia redakcyjna
Tytuł:
The impact of patient sex on characteristic-adjusted bladder cancer prognosis.
Autorzy:
Zhao C; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Li K; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Zhu M; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Wang F; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Zhang K; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Fan C; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Wang J; Department of Urology, Suzhou Municipal Hospital, The Affiliated Suzhou Hospital of Nanjing Medical University, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, PR China.
Pokaż więcej
Źródło:
Journal of cancer research and therapeutics [J Cancer Res Ther] 2021 Nov; Vol. 17 (5), pp. 1241-1247.
Typ publikacji:
Journal Article
MeSH Terms:
Cystectomy/*mortality
Muscle Neoplasms/*mortality
Urinary Bladder Neoplasms/*mortality
Adult ; Aged ; Aged, 80 and over ; Body Mass Index ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Muscle Neoplasms/pathology ; Muscle Neoplasms/surgery ; Neoplasm Invasiveness ; Prognosis ; Sex Factors ; Survival Rate ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł:
Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II Study.
Autorzy:
Shi H; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang W; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bi X; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang D; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xiao Z; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guan Y; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Guan K; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Tian J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Bai H; Department of Urology, Cancer Hospital of Huanxing Chaoyang District Beijing, Beijing, China.
Hu L; Department of Urology, Cancer Hospital of Huanxing Chaoyang District Beijing, Beijing, China.
Cao C; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jiang W; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Hu Z; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhang J; Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chen Y; Department of Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zheng S; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Feng X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li C; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Li Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ma J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Liu Y; Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhou A; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Shou J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2021 Oct; Vol. 53 (4), pp. 1156-1165. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Chemoradiotherapy/*mortality
Cystectomy/*mortality
Muscle Neoplasms/*therapy
Neoadjuvant Therapy/*mortality
Neoplasm Recurrence, Local/*therapy
Organ Sparing Treatments/*mortality
Urinary Bladder Neoplasms/*therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cisplatin/administration & dosage ; Combined Modality Therapy ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Muscle Neoplasms/pathology ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Prospective Studies ; Quality of Life ; Remission Induction ; Retrospective Studies ; Survival Rate ; Urinary Bladder Neoplasms/pathology ; Gemcitabine
Czasopismo naukowe
Tytuł:
The KrasG12D;Trp53fl/fl murine model of undifferentiated pleomorphic sarcoma is macrophage dense, lymphocyte poor, and resistant to immune checkpoint blockade.
Autorzy:
Hildebrand KM; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; McCaig Bone and Joint Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Singla AK; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; McCaig Bone and Joint Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
McNeil R; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Marritt KL; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; McCaig Bone and Joint Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Hildebrand KN; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; McCaig Bone and Joint Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Zemp F; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
Rajwani J; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
Itani D; Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI, United States of America.
Bose P; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Mahoney DJ; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
Jirik FR; McCaig Bone and Joint Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Monument MJ; Department of Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; McCaig Bone and Joint Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.; Arnie Charbonneau Cancer Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Jul 09; Vol. 16 (7), pp. e0253864. Date of Electronic Publication: 2021 Jul 09 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immune Checkpoint Inhibitors/*pharmacology
Muscle Neoplasms/*genetics
Proto-Oncogene Proteins p21(ras)/*genetics
Sarcoma/*genetics
Tumor Suppressor Protein p53/*genetics
Animals ; Cell Line, Tumor ; Disease Models, Animal ; Drug Resistance, Neoplasm/genetics ; Female ; Hindlimb ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Lymphocytes, Tumor-Infiltrating/immunology ; Macrophages/immunology ; Male ; Mice ; Mice, Transgenic ; Muscle Neoplasms/immunology ; Muscle Neoplasms/pathology ; Muscle, Skeletal/pathology ; Mutation ; Sarcoma/immunology ; Sarcoma/pathology ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł:
The discovery of bacterial biofilm in patients with muscle invasive bladder cancer.
Autorzy:
Nadler N; Department of Urology, Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Kvich L; Costerton Biofilm Center, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Surgery, Zealand University Hospital, Koege, Denmark.
Bjarnsholt T; Costerton Biofilm Center, Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Jensen JB; Department of Urology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Gögenur I; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Department of Surgery, Zealand University Hospital, Koege, Denmark.
Azawi N; Department of Urology, Zealand University Hospital, Roskilde, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Źródło:
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2021 May; Vol. 129 (5), pp. 265-270. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Bacteria/*isolation & purification
Biofilms/*growth & development
Muscle Neoplasms/*microbiology
Urinary Bladder Neoplasms/*microbiology
Aged ; Aged, 80 and over ; Carcinoma, Squamous Cell/microbiology ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Cystoscopy ; Female ; Humans ; Male ; Muscle Neoplasms/pathology ; Muscle Neoplasms/surgery ; Neoplasm Invasiveness ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł:
A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer.
Autorzy:
Uysal D; Department of Urology and Urosurgery, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Kowalewski KF; Department of Urology and Urosurgery, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Kriegmair MC; Department of Urology and Urosurgery, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Wirtz R; STRATIFYER Molecular Pathology GmbH, Köln, Germany.
Popovic ZV; Institute of Pathology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Erben P; Department of Urology and Urosurgery, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Mar 12; Vol. 16 (3), pp. e0248342. Date of Electronic Publication: 2021 Mar 12 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chromosomes, Human, Pair 8*/genetics
Chromosomes, Human, Pair 8*/metabolism
Gene Expression Regulation, Neoplastic*
Muscle Neoplasms*/genetics
Muscle Neoplasms*/metabolism
Muscle Neoplasms*/mortality
Neoplasm Proteins*/biosynthesis
Neoplasm Proteins*/genetics
RNA, Messenger*/biosynthesis
RNA, Messenger*/genetics
RNA, Neoplasm*/biosynthesis
RNA, Neoplasm*/genetics
Transcription Factors*/biosynthesis
Transcription Factors*/genetics
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/mortality
Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Invasiveness ; Prognosis ; Retrospective Studies ; Survival Rate
Czasopismo naukowe
Tytuł:
Surgical excision of a malignant metastatic melanoma located in a skeletal muscle of the lateral thorax of a horse.
Autorzy:
Billi T; Faculty of Health Sciences, Equine Unit, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Karadima V; Faculty of Health Sciences, Equine Unit, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Tyrnenopoulou P; Faculty of Health Sciences, Equine Unit, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Apostolopoulou EP; Faculty of Health Sciences, Laboratory of Pathology, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Brellou GD; Faculty of Health Sciences, Laboratory of Pathology, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Diakakis N; Faculty of Health Sciences, Equine Unit, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2021 Mar; Vol. 7 (2), pp. 297-302. Date of Electronic Publication: 2020 Sep 29.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Horse Diseases/*surgery
Melanoma/*veterinary
Muscle Neoplasms/*veterinary
Muscle, Skeletal/*pathology
Animals ; Horse Diseases/pathology ; Horses ; Male ; Melanoma/secondary ; Melanoma/surgery ; Muscle Neoplasms/secondary ; Muscle Neoplasms/surgery ; Muscle, Skeletal/surgery ; Neoplasm Metastasis ; Skin Neoplasms/pathology ; Skin Neoplasms/veterinary ; Thorax/pathology
Czasopismo naukowe
Tytuł:
Smooth muscle hamartoma and striated muscle hamartoma: Clinicopathologic characterization of two rare entities and literature review.
Autorzy:
González IA; The Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pathology and Immunology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.; The Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Dehner LP; The Lauren V. Ackerman Laboratory of Surgical Pathology, Department of Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2021 Feb; Vol. 48 (2), pp. 237-246. Date of Electronic Publication: 2020 Nov 08.
Typ publikacji:
Case Reports; Journal Article; Review
MeSH Terms:
Hamartoma*/metabolism
Hamartoma*/pathology
Head and Neck Neoplasms*/metabolism
Head and Neck Neoplasms*/pathology
Muscle Neoplasms*/metabolism
Muscle Neoplasms*/pathology
Muscle, Smooth*/metabolism
Muscle, Smooth*/pathology
Muscle, Striated*/metabolism
Muscle, Striated*/pathology
Adolescent ; Adult ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Male
Czasopismo naukowe
Tytuł:
An unusual location of a cavernous hemangioma: a case report.
Autorzy:
Sayad Z; Department of Oral and Maxillofacial Surgery, Ibn Sina University Hospital Center, Rabat, Morocco.
Dani B; Department of Oral and Maxillofacial Surgery, Ibn Sina University Hospital Center, Rabat, Morocco.
Benazzou S; Department of Oral and Maxillofacial Surgery, Ibn Sina University Hospital Center, Rabat, Morocco.
Boulaadas M; Department of Oral and Maxillofacial Surgery, Ibn Sina University Hospital Center, Rabat, Morocco.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2021 May 11; Vol. 39, pp. 29. Date of Electronic Publication: 2021 May 11 (Print Publication: 2021).
Typ publikacji:
Case Reports
MeSH Terms:
Hemangioma, Cavernous/*diagnosis
Muscle Neoplasms/*diagnosis
Temporal Muscle/*pathology
Adult ; Female ; Hemangioma, Cavernous/pathology ; Humans ; Muscle Neoplasms/pathology
Raport
Tytuł:
[Mazabraud syndrome].
Autorzy:
Martínez-Peniche JL; Ortopedia y Traumatología. Centro Médico ABC. México.
Harfush-Nasser LA; Ortopedia y Traumatología. Centro Médico ABC. México.
Fernández de Lara-Barrera Y; Imagenología. Centro Médico ABC. México.
Cuesta-Mejías TC; Anatomía Patológica. Centro Médico ABC. México.
Molinar-Flores G; Anatomía Patológica. Centro Médico ABC. México.
Pokaż więcej
Transliterated Title:
Síndrome de Mazabraud.
Źródło:
Acta ortopedica mexicana [Acta Ortop Mex] 2021 Mar-Apr; Vol. 35 (2), pp. 221-225.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Fibrous Dysplasia of Bone*
Fibrous Dysplasia, Polyostotic*
Muscle Neoplasms*/diagnostic imaging
Myxoma*/diagnosis
Myxoma*/surgery
Adult ; Female ; Humans ; Magnetic Resonance Imaging ; Syndrome
Czasopismo naukowe
Tytuł:
Will virtual multidisciplinary team meetings become the norm for musculoskeletal oncology care following the COVID-19 pandemic? - experience from a tertiary sarcoma centre.
Autorzy:
Rajasekaran RB; The Oxford Bone Tumour & Soft Tissue Sarcoma Service, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, 17, Horwood Close, Headington, Windmill Road, Oxford, OX3 7LD, UK. .
Whitwell D; The Oxford Bone Tumour & Soft Tissue Sarcoma Service, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, 17, Horwood Close, Headington, Windmill Road, Oxford, OX3 7LD, UK.
Cosker TDA; The Oxford Bone Tumour & Soft Tissue Sarcoma Service, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, 17, Horwood Close, Headington, Windmill Road, Oxford, OX3 7LD, UK.
Gibbons CLMH; The Oxford Bone Tumour & Soft Tissue Sarcoma Service, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, 17, Horwood Close, Headington, Windmill Road, Oxford, OX3 7LD, UK.
Carr A; Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Pokaż więcej
Źródło:
BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2021 Jan 05; Vol. 22 (1), pp. 18. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji:
Journal Article
MeSH Terms:
COVID-19*
Interdisciplinary Communication*
Bone Neoplasms/*therapy
Medical Oncology/*organization & administration
Muscle Neoplasms/*therapy
Patient Care Team/*organization & administration
Sarcoma/*therapy
Telemedicine/*organization & administration
Videoconferencing/*organization & administration
Attitude of Health Personnel ; Attitude to Computers ; Bone Neoplasms/diagnosis ; Clinical Decision-Making ; Delivery of Health Care, Integrated/organization & administration ; Health Knowledge, Attitudes, Practice ; Humans ; Muscle Neoplasms/diagnosis ; Sarcoma/diagnosis ; Tertiary Care Centers
Czasopismo naukowe
Tytuł:
Treatment patterns and clinical outcomes of chemotherapy treatment in patients with muscle-invasive or metastatic bladder cancer in the Netherlands.
Autorzy:
Reesink DJ; Urology Department, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein/Utrecht, The Netherlands. .
van de Garde EMW; Clinical Pharmacy Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands.
Peters BJM; Clinical Pharmacy Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands.
van der Nat PB; Value Based Healthcare Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands.
Los M; Oncology Department, St. Antonius Hospital, Nieuwegein/Utrecht, The Netherlands.
Horenblas S; Urology Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van Melick HHE; Urology Department, St. Antonius Hospital, Koekoekslaan 1, 3435CM, Nieuwegein/Utrecht, The Netherlands.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Sep 25; Vol. 10 (1), pp. 15822. Date of Electronic Publication: 2020 Sep 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Muscle Neoplasms/*mortality
Neoadjuvant Therapy/*mortality
Urinary Bladder Neoplasms/*mortality
Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Muscle Neoplasms/drug therapy ; Muscle Neoplasms/secondary ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Netherlands ; Retrospective Studies ; Survival Rate ; Treatment Outcome ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology
Czasopismo naukowe
Tytuł:
Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
Autorzy:
Zhu G; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China.
Wang K; School of Pharmacy, Nantong University, Nantong, 226001, China.
Qin H; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China.
Zhao X; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China.
Chen W; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China.
Xu L; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China.
Cao W; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China.
Guo H; Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210009, China. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2020 Sep 04; Vol. 18 (1), pp. 124. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents/*pharmacology
Muscle Neoplasms/*drug therapy
Nanoparticles/*chemistry
Nanoparticles/*therapeutic use
Polymers/*chemistry
Urinary Bladder Neoplasms/*drug therapy
Animals ; Antineoplastic Agents/chemistry ; Cell Line, Tumor ; Combined Modality Therapy ; Disease Models, Animal ; Drug Delivery Systems ; Drug Therapy/methods ; Humans ; Infrared Rays ; Laser Therapy ; Lasers ; Mice ; Mice, Inbred C57BL ; Muscle Neoplasms/pathology ; Muscle Neoplasms/radiotherapy ; Muscles/drug effects ; Phototherapy/methods ; Polyethylene Glycols ; Sensitivity and Specificity ; Succinimides ; Urinary Bladder Neoplasms/pathology ; Urinary Bladder Neoplasms/radiotherapy
Czasopismo naukowe
Tytuł:
Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer.
Autorzy:
van der Vos KE; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Vis DJ; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Nevedomskaya E; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kim Y; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Choi W; Johns Hopkins Greenberg Bladder Cancer Institute, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
McConkey D; Johns Hopkins Greenberg Bladder Cancer Institute, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
Wessels LFA; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of EEMCS, Delft University of Technology, Delft, The Netherlands.
van Rhijn BWG; Department of Surgical Oncology (Urology), The Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Zwart W; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
van der Heijden MS; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Jul 02; Vol. 10 (1), pp. 10952. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Methylation*
Epigenesis, Genetic*
Gene Expression Regulation, Neoplastic*
Biomarkers, Tumor/*genetics
Cystectomy/*methods
Muscle Neoplasms/*pathology
Urinary Bladder Neoplasms/*pathology
Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Gene Expression Profiling ; Humans ; Male ; Middle Aged ; Muscle Neoplasms/classification ; Muscle Neoplasms/genetics ; Muscle Neoplasms/surgery ; Neoplasm Invasiveness ; Prognosis ; Urinary Bladder Neoplasms/classification ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł:
JUND-dependent up-regulation of HMOX1 is associated with cisplatin resistance in muscle-invasive bladder cancer.
Autorzy:
Peng Y; Department of Orthopaedics, Air Force Medical Center, PLA, No. 30 Fucheng Road, Beijing 100142, China.
Chen Y; Department of Urology, 73rd Group Army Hospital, PLA Army, No. 94 Wenyuan Road, Xia'men 361000, China.
Chen S; Department of Urology, 73rd Group Army Hospital, PLA Army, No. 94 Wenyuan Road, Xia'men 361000, China.
Wang J; Department of Urology, 73rd Group Army Hospital, PLA Army, No. 94 Wenyuan Road, Xia'men 361000, China.
Jiang C; Department of Urology, 73rd Group Army Hospital, PLA Army, No. 94 Wenyuan Road, Xia'men 361000, China.
Hou W; Department of Anesthesiology and Perioperative Medicine, Xijing Hospital, Fourth Military Medical University, No. 127 Changle West Road, Xi'an 710032, China.
Xu C; Department of Urology, 73rd Group Army Hospital, PLA Army, No. 94 Wenyuan Road, Xia'men 361000, China.
Pokaż więcej
Źródło:
Journal of biochemistry [J Biochem] 2020 Jul 01; Vol. 168 (1), pp. 73-82.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Neoplasm*
Gene Expression Regulation, Neoplastic*
Cisplatin/*therapeutic use
Heme Oxygenase-1/*metabolism
Muscle Neoplasms/*pathology
Proto-Oncogene Proteins c-jun/*metabolism
Urinary Bladder Neoplasms/*pathology
Animals ; Antineoplastic Agents/therapeutic use ; Cell Line, Tumor ; Heme Oxygenase-1/genetics ; Humans ; Mice ; Mice, Nude ; Muscle Neoplasms/genetics ; Muscle Neoplasms/metabolism ; Prognosis ; Proto-Oncogene Proteins c-jun/genetics ; Signal Transduction ; Survival Rate ; Up-Regulation ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/metabolism
Czasopismo naukowe
Tytuł:
[Fibromatosis colli: a rare cervical tumor of the infant].
Autorzy:
Lengane NI; Service ORL et Chirurgie Cervicofaciale, CHU Régional de Ouahigouya, Ouahigouya, Burkina Faso.
Some MJM; Service d´Imagerie Médicale, CHU Régional de Ouahigouya, Ouahigouya, Burkina Faso.
Tall M; Service d´Imagerie Médicale, CHU Régional de Ouahigouya, Ouahigouya, Burkina Faso.
Ouermi AS; Service de Pédiatrie, CHU Régional de Ouahigouya, Ouahigouya, Burkina Faso.
Nikiema JP; Service de Pédiatrie, CHU Régional de Ouahigouya, Ouahigouya, Burkina Faso.
Ouoba JW; Service ORL et Chirurgie Cervicofaciale, CHU Pédiatrique Charles De Gaulle, Ouagadougou, Burkina Faso.
Kadyogo M; Service ORL et Chirurgie Cervicofaciale, CHU Bogodogo, Ouagadougou, Burkina Faso.
Sereme M; Service ORL et Chirurgie Cervicofaciale, CHU Bogodogo, Ouagadougou, Burkina Faso.
Pokaż więcej
Transliterated Title:
Le fibromatosis colli: une tumeur cervicale rare du nourrisson.
Źródło:
The Pan African medical journal [Pan Afr Med J] 2020 Dec 23; Vol. 37, pp. 370. Date of Electronic Publication: 2020 Dec 23 (Print Publication: 2020).
Typ publikacji:
Case Reports
MeSH Terms:
Fibroma/*diagnostic imaging
Head and Neck Neoplasms/*diagnostic imaging
Muscle Neoplasms/*diagnostic imaging
Neck Muscles/*diagnostic imaging
Female ; Fibroma/pathology ; Head and Neck Neoplasms/pathology ; Humans ; Infant ; Male ; Muscle Neoplasms/pathology ; Neck Muscles/pathology ; Ultrasonography
Raport

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies